Monday, May 10, 2021

Best Blue Chip Stocks To Buy For 2021

tags:MIC,VBLT,CORT,SOHU,ADS,

Brokerages forecast that News Corp (NASDAQ:NWSA) will announce $2.55 billion in sales for the current quarter, according to Zacks Investment Research. Two analysts have provided estimates for News’ earnings. The highest sales estimate is $2.59 billion and the lowest is $2.52 billion. News reported sales of $2.06 billion during the same quarter last year, which indicates a positive year-over-year growth rate of 23.8%. The business is scheduled to issue its next earnings report on Thursday, November 8th.

On average, analysts expect that News will report full-year sales of $10.52 billion for the current fiscal year, with estimates ranging from $10.43 billion to $10.64 billion. For the next financial year, analysts expect that the company will report sales of $10.63 billion, with estimates ranging from $10.50 billion to $10.75 billion. Zacks’ sales calculations are an average based on a survey of sell-side research firms that follow News.

Best Blue Chip Stocks To Buy For 2021: Macquarie Infrastructure Company(MIC)

Macquarie Infrastructure Company LLC, through its subsidiaries, owns, operates, and invests in infrastructure businesses that provide services to businesses and individuals primarily in the United States. It operates through four segments: International-Matex Tank Terminals (IMTT), Atlantic Aviation, Contracted Power and Energy (CP&E), and Hawaii Gas. The IMTT segment offers bulk liquid storage, handling, and other services for petroleum products, various chemicals, renewable fuels, and vegetable and animal oils at 10 marine terminals in the United States and 2 marine terminals in Canada. This segment also provides environmental emergency responses, industrial services, and waste transportation and disposal services. The Atlantic Aviation segment offers fueling and fuel-related services, aircraft parking, and hangar services to owners/operators of jet aircraft primarily in the general aviation, commercial, military, freight, and government aviation sectors at 69 airports in the United States. The CP&E segment generates electricity through renewable energy sources. As of December 31, 2014, it had interests in five solar power generating facilities with an aggregate generating capacity of 57 megawatts (MW) located in Arizona, California, and Texas; and two wind power generating facilities with an aggregate generating capacity of 203 MW located in New Mexico and Idaho. The Hawaii Gas segment engages in processing, distributing, and selling synthetic natural gas and liquefied natural gas; and distributing and selling liquefied petroleum gas to residential, commercial, hospitality, military, and wholesale customers, as well as to public sector in Oahu, Hawaii, Maui, Kauai, Molokai, and Lanai. This segment's products are used in various commercial and residential applications, such as water heating, drying, cooking, emergency power generation, and decorative lighting, as well as for specialty vehicles. The company was founded in 2004 and is based in New York, New York.

Advisors' Opinion:

  • [By Max Byerly]

    Mindexcoin (CURRENCY:MIC) traded down 27.7% against the dollar during the 24 hour period ending at 0:00 AM Eastern on February 9th. During the last week, Mindexcoin has traded down 45.4% against the dollar. One Mindexcoin token can now be bought for approximately $0.0164 or 0.00000448 BTC on major cryptocurrency exchanges including EtherDelta (ForkDelta), LATOKEN, Mercatox and Token Store. Mindexcoin has a market capitalization of $386,072.00 and $4,364.00 worth of Mindexcoin was traded on exchanges in the last 24 hours.

  • [By Money Morning Staff Reports]

    Macquarie Infrastructure Corp. (NYSE: MIC) operates a portfolio of contract power facilities, bulk liquid terminals for natural gas, jet fuel terminals, and energy power and distribution systems.

  • [By Ethan Ryder]

    Mindexcoin (CURRENCY:MIC) traded 155.9% higher against the US dollar during the 24-hour period ending at 16:00 PM E.T. on September 30th. Mindexcoin has a market capitalization of $2.30 million and approximately $34,715.00 worth of Mindexcoin was traded on exchanges in the last day. During the last week, Mindexcoin has traded up 199.4% against the US dollar. One Mindexcoin token can currently be bought for about $0.18 or 0.00002672 BTC on exchanges including Token Store, Mercatox, LATOKEN and EtherDelta (ForkDelta).

  • [By Stephan Byrd]

    Schwab Charles Investment Management Inc. boosted its stake in Macquarie Infrastructure Corp (NYSE:MIC) by 26.9% during the second quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 468,166 shares of the conglomerate’s stock after buying an additional 99,139 shares during the quarter. Schwab Charles Investment Management Inc.’s holdings in Macquarie Infrastructure were worth $19,757,000 as of its most recent filing with the SEC.

Best Blue Chip Stocks To Buy For 2021: Vascular Biogenics Ltd.(VBLT)

Vascular Biogenics Ltd., incorporated on January 31, 2000, is a clinical-stage biopharmaceutical company. The Company is focused on the discovery, development and commercialization of treatments for cancer. The Company's program is based on its Vascular Targeting System (VTS) platform technology, which utilizes genetically targeted therapy to destroy newly formed, or angiogenic, blood vessels. Its lead product candidate, VB-111(ofranergene obadenovec), is a gene-based biologic that it is developing for solid tumor indications, with a program for recurrent glioblastoma (rGBM), a form of brain cancer. It also is engaged in conducting a program focusing anti-inflammatory diseases, based on the use of its Lecinoxoid platform technology. Lecinoxoids are a class of small molecules it developed that are structurally and functionally similar to naturally occurring molecules known to modulate inflammation. The lead product candidate from this program, VB-201, is a Phase II-ready molecule that demonstrated efficacy in reducing vascular inflammation in a Phase II sub-study in psoriatic patients with cardiovascular risk.

VTS Platform

The Company's VTS platform technology enables systemic administration of gene therapy to either destroy or promote angiogenic blood vessels. VTS is both tissue- and condition-specific, allowing for targeted and limited gene expression in endothelial cells, the thin layer of cells that lines the interior surface of blood vessels undergoing angiogenesis. Its VTS platform technology comprises three components: a viral vector, a promoter and a transgene. The viral vector is a modified virus that is used as a delivery vehicle to distribute the promoter and the transgene throughout the body. The promoter is its genetically modified promoter, PPE-1-3X, which specifically targets the endothelial cells of angiogenic blood vessels. The transgene is a genetic sequence designed to yield a specific biologic effect, the expression of which is directed by PPE-1-3X.

The Company has studied VB-111 in a Phase I all comers trial involving patients with multiple types of metastatic cancer types, including thyroid cancer, neuroendocrine cancer, renal cell carcinoma and lung cancer. In that trial, VB-111 was tolerated and showed a dose- dependent extension in median overall survival across a range of tumor types. Its VTS platform technology enables systemic administration of gene therapy to either destroy or promote angiogenic blood vessels. It has also generated additional product candidates, which utilize the same vector and promoter as in VB-111, and comprise alternative functional transgenes, which include VB-511, an anti-angiogenic candidate; VB-211 and VB-411, which are pro-angiogenic candidates that may be employed for ischemic conditions, such as peripheral vascular disease.

Lecinoxoid Platform

The Company's Lecinoxoid platform technology comprises a family of orally administered small molecules designed to modulate the body's inflammatory response. Lecinoxoids are compounds that are structurally and functionally similar to naturally occurring molecules, known as oxidized phospholipids, which possess immune modulating anti-inflammatory properties, modified to manage stability and activity. Its lead Lecinoxoid-based compound, VB-201, is designed as an oral agent for the control of chronic inflammatory disorders. VB-201 inhibits the CD-14/TLR4 and TLR2 pathways, as well as monocyte migration. The Company has also developed second and third generations of Lecinoxoid product candidates.

Advisors' Opinion:
  • [By Lisa Levin]

    Check out these big penny stock gainers and losers

    Losers ReTo Eco-Solutions, Inc. (NASDAQ: RETO) fell 9.3 percent to $4.50 in pre-market trading. ProPhase Labs, Inc. (NASDAQ: PRPH) shares fell 8.5 percent to $4.50 in pre-market trading after dropping 3.53 percent on Thursday. Nordstrom, Inc. (NYSE: JWN) fell 7.5 percent to $47.10 in pre-market trading. Nordstrom reported upbeat results for its first quarter. Comparable-store sales rose 0.6 percent. Baidu, Inc. (NASDAQ: BIDU) shares fell 6 percent to $263.00 in pre-market trading. Baidu disclosed that its COO Qi Lu will step down in July 2018. Riot Blockchain, Inc. (NASDAQ: RIOT) shares fell 5.6 percent to $8.98 in pre-market trading after climbing 11.88 percent on Thursday. Applied Materials, Inc. (NASDAQ: AMAT) fell 5 percent to $51.30 in pre-market trading. Applied Materials reported stronger-than-expected results for its second quarter, but issued weak sales outlook for the third quarter. Blink Charging Co. (NASDAQ: BLNK) fell 5 percent to $7.61 in pre-market trading after rising 11.40 percent on Thursday. Illumina, Inc. (NASDAQ: ILMN) shares fell 4.7 percent to $255.77 in pre-market trading. Vascular Biogenics Ltd (NASDAQ: VBLT) fell 4.6 percent to $2.10 in pre-market trading after reporting a first-quarter earnings miss. Campbell Soup Company (NYSE: CPB) fell 3.3 percent to $37.60 in pre-market trading. Campbell Soup reported upbeat Q3 earnings, but sales missed estimates. The company also lowered its FY18 outlook. ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD) shares fell 2.7 percent to $17.65 in pre-market trading after reporting a 7.2 million common stock offering
  • [By Lisa Levin] Companies Reporting Before The Bell Walmart Inc. (NYSE: WMT) is estimated to report quarterly earnings at $1.13 per share on revenue of $120.51 billion. J. C. Penney Company, Inc. (NYSE: JCP) is expected to report quarterly loss at $0.2 per share on revenue of $2.63 billion. Dillard's, Inc. (NYSE: DDS) is projected to report quarterly earnings at $2.77 per share on revenue of $1.46 billion. The Children's Place, Inc. (NASDAQ: PLCE) is estimated to report quarterly earnings at $2.21 per share on revenue of $444.14 million. Manchester United plc (NYSE: MANU) is expected to report quarterly loss at $1.35 per share on revenue of $193.67 million. Teekay Corporation (NYSE: TK) is estimated to report quarterly loss at $0.08 per share on revenue of $296.76 million. KEMET Corporation (NYSE: KEM) is projected to report quarterly earnings at $0.41 per share on revenue of $306.72 million. Vascular Biogenics Ltd. (NASDAQ: VBLT) is estimated to report a quarterly loss at $0.21 per share. Teekay Offshore Partners L.P. (NYSE: TOO) is expected to report quarterly earnings at $0.04 per share on revenue of $272.04 million. Albireo Pharma, Inc. (NASDAQ: ALBO) is expected to report quarterly earnings at $1.77 per share on revenue of $31.32 million.

     

Best Blue Chip Stocks To Buy For 2021: Corcept Therapeutics Incorporated(CORT)

We are a pharmaceutical company engaged in the discovery, development and commercialization of drugs that treat severe metabolic, oncologic and psychiatric disorders by modulating the effects of cortisol. Elevated levels and abnormal release patterns of cortisol are implicated in a broad range of human disorders. Since our inception in 1998, we have been developing mifepristone, a compound that modulates the effects of cortisol by acting as a competitive antagonist at the glucocorticoid receptor (GR). We have also discovered three structurally distinct series of proprietary, selective cortisol modulators, all of which share mifepristone's affinity for GR but, unlike mifepristone, do not bind to the progesterone receptor, and so do not terminate pregnancy or cause other side effects associated with progesterone receptor antagonism. We have begun pre-clinical and clinical development of our lead compounds from these series.   Advisors' Opinion:

  • [By Maxx Chatsko]

    Shares of Corcept Therapeutics (NASDAQ:CORT) gained over 11% last month, according to data provided by S&P Global Market Intelligence. The double-digit rise might seem impressive, but it comes on the heels of a report by the Southern Investigative Reporting Foundation (SIRF) that painted the company and its main profit generator, Korlym, a drug approved to treat Cushing's syndrome, in a negative light. That caused the stock to plunge in late January. As a result, shares have posted a year-to-date loss of 6% through the first week of March.

  • [By Stephan Byrd]

    Get a free copy of the Zacks research report on Corcept Therapeutics (CORT)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Motley Fool Transcribers]

    Corcept Therapeutics Incorporated  (NASDAQ:CORT)Q4 2018 Earnings Conference CallFeb. 25, 2019, 5:00 p.m. ET

    Contents: Prepared Remarks Questions and Answers Call Participants Prepared Remarks:

    Operator

  • [By Ethan Ryder]

    BidaskClub upgraded shares of Corcept Therapeutics (NASDAQ:CORT) from a sell rating to a hold rating in a research report report published on Monday morning.

Best Blue Chip Stocks To Buy For 2021: Sohu.com Inc.(SOHU)

Sohu.com Inc. provides online media, search, and game services on personal computers (PCs), mobile devices, and tablets in the People's Republic of China. It operates brand advertising business that offers advertisements on its Websites to companies; sohu.com, which provides online news and information; m.sohu.com mobile portal and Sohu News APP, a mobile phone application; tv.sohu.com, which offers online video service; and focus.cn that provides online real estate information. The company's search and search-related business provides Sogou Input Method software to input Chinese characters on PCs and mobile devices; Sogou browser; Sogou Web Directory, a Web directory navigation site for PCs; Sogou Search, a proprietary search engine; and Sogou Browser for PCs and mobile devices, as well as offers pay-for-click services and online marketing services for advertisers. In addition, its online game business offers interactive online games, mobile games, and Web games for game players. Further, the company's platform channel business owns and operates various Web properties and software applications, including 17173.com, an information portal for game players; RaidCall, which provides online music and entertainment services; and the Dolphin Browser, a gateway to a host of user activities on mobile devices. Additionally, it provides mobile-related services and mobile products; Internet value-added services; and cinema advertising services. The company was formerly known as Internet Technologies China Incorporated and changed its name to Sohu.com Inc. in September 1999. Sohu.com Inc. was founded in 1996 and is headquartered in Beijing, the People's Republic of China.

Advisors' Opinion:

  • [By Rick Munarriz]

    Sohu.com (NASDAQ:SOHU) is still struggling to fire on all cylinders, but investors nonetheless bid shares of the dot-com pioneer higher on Friday after it posted mixed fourth-quarter results. Revenue clocked in at $482.2 million for the final three months of 2018, a 5% decline from a year earlier, but a 5% sequential improvement. 

  • [By Rick Munarriz]

    Lumber Liquidators (NYSE:LL), Camping World Holdings (NYSE:CWH), and Sohu.com (NASDAQ:SOHU) have taken a beating this year. They're among the biggest losers through the first three quarters of 2018. Let's go over why I think they have a shot at bouncing back in the next three months.

  • [By Anders Bylund]

    Sogou's shares are prone to big swings for a couple of simple reasons.

    As a Chinese business, many American investors don't feel connected to Sogou's business and might not have access to some important sources of information about this company and its stock. Though Sogou has been around for nearly a decade now, it only entered the public markets in November of 2017. It's a new ticker, untested on the market, and not always easily understood through year-over-year or longer-term analyses. At the IPO, Chinese internet giants Tencent (NASDAQOTH:TCEHY) and Sohu.com (NASDAQ:SOHU) combined for a total ownership of 82% of Sogu's business. Those stakes later declined to 71%, but Sohu and Tencent remain Sogou's largest shareholders, with 96% of the voting power in shareholder elections and votes. Regular investors hold a very small stake in Sogou, which tends to boost the stock's volatility.

    Moreover, Chinese regulators launched an investigation of Sogou in June, forcing the company to shut down parts of its online advertising operations for 10 days in early July. The company is accused of showing video ads that insulted a national hero. That blackout will reduce Sogou's third-quarter revenues by a significant but unannounced amount.

Best Blue Chip Stocks To Buy For 2021: Alliance Data Systems Corporation(ADS)

Alliance Data Systems Corporation, incorporated on February 23, 1995, is a provider of data-driven marketing and loyalty solutions serving consumer-based businesses in a range of industries. The Company offers a portfolio of integrated outsourced marketing solutions, including customer loyalty programs, database marketing services, end-to-end marketing services, analytics and creative services, direct marketing services, and private label and co-brand retail credit card programs. The Company operates through three segments: LoyaltyOne, which provides coalition and short-term loyalty programs through the Company's Canadian AIR MILES Reward Program and BrandLoyalty; Epsilon, which provides end-to-end, integrated marketing solutions, and Card Services, which provides risk management solutions, account origination, funding, transaction processing, customer care, collections and marketing services for the Company's private label and co-brand retail credit card programs. Its client base is diversified across a range of end-markets, including financial services, specialty retail, grocery and drugstore chains, petroleum retail, automotive, hospitality and travel, telecommunications, insurance and healthcare.

LoyaltyOne

The Company's LoyaltyOne clients are focused on acquiring and retaining customers. The Company uses the information gathered through its loyalty programs to help its clients design and implement marketing programs. Its clients within the LoyaltyOne segment include financial services providers, grocers, drug stores, petroleum retailers and specialty retailers. LoyaltyOne operates the AIR MILES Reward Program and BrandLoyalty. The AIR MILES Reward Program enables consumers, referred to as collectors, to earn AIR MILES reward miles as they shop across a range of retailers and other sponsors participating in the AIR MILES Reward Program. These AIR MILES reward miles can be redeemed by its collectors for travel or other rewards. Through its AIR MILES Cash program option, co! llectors can also redeem their AIR MILES reward miles collected in the AIR MILES Cash program option toward in-store purchases at participating sponsors.

The three primary parties involved in the Company's AIR MILES Reward Program are sponsors, collectors and suppliers. The AIR MILES Reward Program is a full service outsourced loyalty program for its sponsors. Collectors earn AIR MILES reward miles at various retail and service locations, including any online presence the sponsor may have. Collectors can also earn AIR MILES reward miles at various locations where collectors can use certain credit cards issued by Bank of Montreal and Amex Bank of Canada. The Company enters into agreements with airlines, manufacturers of consumer electronics and other providers to supply rewards for the AIR MILES Reward Program. BrandLoyalty designs, organizes, implements and evaluates tailor-made loyalty programs for grocers across the world.

Epsilon

Epsilon is a marketing services firm providing end-to-end, integrated marketing solutions. Its services include strategic consulting, customer database technologies, omnichannel marketing, loyalty management, proprietary data, predictive modeling, permission-based e-mail marketing, personalized digital marketing and a range of direct and digital agency services. On behalf of its clients, the Company develops marketing programs for individual consumers with targeted offers and personalized communications. It distributes marketing campaigns and communications through all marketing channels based on the consumer's preference, including direct mail and digital platforms, such as e-mail, mobile, display and social media. Epsilon has over 1,300 clients, operating primarily in the financial services, insurance, media and entertainment, automotive, consumer packaged goods, retail, travel and hospitality, pharmaceutical/healthcare and telecommunications industries.

For consumer-facing brands, the Company designs, builds and operates! complex ! consumer marketing databases, including loyalty program management, such as Hilton HHonors, Walgreens Balance Rewards and the Citi Thank You programs. The Company provides behavior-based, demographic and attitudinal customer segmentation, purchase analysis, Web analytics, marketing mix modeling, program optimization, predictive modeling, and program measurement and analysis.

Card Services

The Company's Card Services segment assists various retailers in extending their brand with a private label and/or co-brand credit card account that can be used by their customers in the store, or through online or catalog purchases. Its Card Services segment provides risk management solutions, account origination and funding services for over 160 private label and co-brand credit card programs. It processes millions of credit card applications each year using automated scoring technology and verification procedures to make risk-based origination decisions when approving new credit card accountholders and establishing their credit limits. The Company's accountholder base consists primarily of middle- to upper-income individuals, in particular women using its credit cards primarily as brand affinity tools. It uses a securitization program as its primary funding vehicle for its credit card receivables.

The Company performs processing services, and provides service and maintenance for private label and co-brand credit card programs. The Company uses automated technology for bill preparation, printing and mailing, and also offers consumers the ability to view, print and pay their bills online. It also provides collection activities on delinquent accounts to support its private label and co-brand credit card programs. Its private label and co-branded credit card programs are designed specifically for retailers and have the flexibility to be customized to accommodate its clients' specific needs. Through its integrated marketing services, the Company designs and implements strategies tha! t assist ! its clients in acquiring, retaining and managing repeat customers. It uses multi-channel marketing communication tools, including in-store, Web, permission-based e-mail, mobile messaging and direct mail to reach its clients' customers.

Advisors' Opinion:
  • [By Evan Niu, CFA]

    Shares of Alliance Data Systems (NYSE:ADS) have plunged today, down by 12% as of 11:30 a.m. EST, after the company reported fourth-quarter earnings results. While the marketing and customer loyalty specialist beat on the bottom line, it missed on the top line.

  • [By Shane Hupp]

    Alliance Data Systems Co. (NYSE:ADS) has been assigned an average recommendation of “Buy” from the twenty-three analysts that are presently covering the firm, MarketBeat reports. Two equities research analysts have rated the stock with a sell rating, seven have assigned a hold rating and thirteen have assigned a buy rating to the company. The average 12-month price objective among brokers that have covered the stock in the last year is $266.73.

  • [By Max Byerly]

    Bank of America assumed coverage on shares of Alliance Data Systems (NYSE:ADS) in a report released on Monday, The Fly reports. The brokerage set a “buy” rating and a $290.00 price target on the business services provider’s stock. Bank of America’s price target would suggest a potential upside of 20.09% from the stock’s current price.

  • [By Max Byerly]

    SG Americas Securities LLC cut its holdings in shares of Alliance Data Systems Co. (NYSE:ADS) by 64.9% in the second quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 2,985 shares of the business services provider’s stock after selling 5,515 shares during the quarter. SG Americas Securities LLC’s holdings in Alliance Data Systems were worth $696,000 at the end of the most recent reporting period.

No comments:

Post a Comment